Xylem (XYL) Stock Forecast & Price Target $119.74 +0.28 (+0.23%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$119.88 +0.14 (+0.12%) As of 04/1/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Xylem - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 10 Analyst RatingsSell0Hold4Buy6 Based on 10 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 4 have given a hold rating, and 6 have given a buy rating for XYL. Consensus Price Target $149.8925.18% Upside According to the 10 analysts' twelve-month price targets for Xylem, the average price target is $149.89. The highest price target for XYL is $165.00, while the lowest price target for XYL is $125.00. The average price target represents a forecasted upside of 25.18% from the current price of $119.74. Get the Latest News and Ratings for XYL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors. Enter your email to sign up for newsletter Sign Up XYL Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy6 Buy rating(s)7 Buy rating(s)8 Buy rating(s)8 Buy rating(s)Hold4 Hold rating(s)4 Hold rating(s)4 Hold rating(s)3 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$149.89$149.90$152.20$134.00Forecasted Upside25.18% Upside15.58% Upside31.26% Upside4.60% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Remove Ads XYL Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History XYL Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Xylem Stock vs. The CompetitionTypeXylemBusiness Services CompaniesS&P 500Consensus Rating Score 2.60 2.72 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside25.18% Upside1,366.76% Upside19.02% UpsideNews Sentiment RatingVery Positive NewsSee Recent XYL NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails2/5/2025Citigroup3 of 5 starsA. KaplowitzSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold2/5/2025Robert W. Baird2 of 5 starsMichael HalloranSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$139.00 ➝ $148.00+12.96%1/24/2025Stifel Nicolaus4 of 5 starsNathan JonesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetBuy ➝ Buy$166.00 ➝ $150.00+23.55%12/12/2024Wolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingB. HewittSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Peer Perform11/6/2024TD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. GiordanoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetHold ➝ Hold$138.00 ➝ $125.00+1.12%11/1/2024Royal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetOutperform ➝ Outperform$163.00 ➝ $162.00+35.02%8/13/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. KarasSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$165.00+29.41%5/31/2024OppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOutperform ➝ Outperform$147.00 ➝ $152.00+9.71%5/29/2024ArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. EadeSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetBuy ➝ Buy$146.00 ➝ $165.00+19.75%5/3/2024MizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetNeutral ➝ Neutral$110.00 ➝ $135.00-0.73% Get the Latest News and Ratings for XYL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter. 3/12/2024BNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$150.00+18.88%1/4/2024Raymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeUnderperform ➝ Market Perform11/21/2023Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeHold ➝ Buy$104.00 ➝ $120.00+19.74%10/2/2023MeliusSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeHold ➝ Buy$122.00+33.46%8/29/2023Seaport Res PtnSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. GrahamSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral6/29/2023888Subscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingInitiatesAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:34 AM ET. Should I Buy Xylem Stock? XYL Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, March 25, 2025. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com. Xylem Bull Case Here are some ways that investors could benefit from investing in Xylem Inc.: Xylem Inc. has shown strong financial performance, reporting earnings per share of $1.18, exceeding analysts' expectations of $1.12, indicating robust profitability. The company has a market capitalization of $29.40 billion, which reflects its significant size and stability in the industrial products sector. Recent upgrades from analysts, including a target price increase from Robert W. Baird to $148.00, suggest positive market sentiment and potential for stock appreciation. Xylem Inc. has a current stock price of $120.96, which may present a buying opportunity for investors looking to enter at a favorable valuation. The company has increased its quarterly dividend from $0.36 to $0.40, demonstrating a commitment to returning value to shareholders and indicating financial health. Xylem Bear Case Investors should be bearish about investing in Xylem Inc. for these reasons: Despite positive earnings, the stock has a relatively high P/E ratio of 33.05, which may indicate that it is overvalued compared to its earnings. Citigroup recently downgraded Xylem from a "strong-buy" to a "hold" rating, which could signal a lack of confidence in the stock's short-term performance. The company has a debt-to-equity ratio of 0.19, which is low, but any increase in debt could impact its financial flexibility and risk profile. Market volatility could affect Xylem's stock price, as indicated by its beta of 1.08, suggesting it is slightly more volatile than the market average. Analysts have mixed ratings, with four holding a "hold" rating, which may indicate uncertainty about the stock's future performance. XYL Forecast - Frequently Asked Questions What is Xylem's forecast for 2025? According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $149.89, with a high forecast of $165.00 and a low forecast of $125.00. Should I buy or sell Xylem stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XYL shares. Does Xylem's stock price have much upside? According to analysts, Xylem's stock has a predicted upside of 25.18% based on their 12-month stock forecasts. Has Xylem been downgraded by Wall Street analysts recently? Over the previous 90 days, Xylem's stock had 1 downgrade by analysts. What analysts cover Xylem? Xylem has been rated by research analysts at Citigroup, Robert W. Baird, and Stifel Nicolaus in the past 90 days. Do Wall Street analysts like Xylem more than its competitors? Analysts like Xylem less than other "business services" companies. The consensus rating score for Xylem is 2.60 while the average consensus rating score for "business services" companies is 2.72. Learn more on how XYL compares to other companies. Stock Forecasts and Research Tools Related Companies PH Stock Forecast ITW Stock Forecast IR Stock Forecast DOV Stock Forecast SNA Stock Forecast PNR Stock Forecast GGG Stock Forecast IEX Stock Forecast SWK Stock Forecast NDSN Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:XYL) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Tax Shock?Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xylem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xylem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
